Natesto — Blue Cross Blue Shield Of Texas
15 indications indexed for this drug.
- Associated Condition Related To Stage Four Metastatic CancerView coverage criteria
- Breast CancerView coverage criteria
- Delayed Puberty In AdolescentsView coverage criteria
- Delayed Puberty In An AdolescentView coverage criteria
- Endometriosis Amenable To Hormone ManagementView coverage criteria
- Gender Dysphoria Gender IncongruenceView coverage criteria
- Myelofibrosis Associated AnemiaView coverage criteria
- Other Approved Androgen Anabolic Steroid IndicationsView coverage criteria
- Other Rare Diseases Per Plan NotesView coverage criteria
- Prevention Of Attacks Of Hereditary AngioedemaView coverage criteria
- Primary HypogonadismView coverage criteria
- Primary Or Secondary Hypogonadotropic HypogonadismView coverage criteria
- Secondary HypogonadismView coverage criteria
- Sex Hormone Treatment For Adults Gender Dysphoria Gender IncView coverage criteria
- Stage Four Advanced Metastatic CancerView coverage criteria